Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Nephrol Dial Transplant. 2023 Jan 23;38(1):212-221. doi: 10.1093/ndt/gfac202.
One of the challenges in living kidney donor screening is to estimate remaining kidney function after donation. Here we developed a new model to predict post-donation measured glomerular filtration rate (mGFR) from pre-donation serum creatinine, age and sex.
In the prospective development cohort (TransplantLines, n = 511), several prediction models were constructed and tested for accuracy, precision and predictive capacity for short- and long-term post-donation 125I-iothalamate mGFR. The model with optimal performance was further tested in specific high-risk subgroups (pre-donation eGFR <90 mL/min/1.73 m2, a declining 5-year post-donation mGFR slope or age >65 years) and validated in internal (n = 509) and external (Mayo Clinic, n = 1087) cohorts.
In the development cohort, pre-donation estimated GFR (eGFR) was 86 ± 14 mL/min/1.73 m2 and post-donation mGFR was 64 ± 11 mL/min/1.73 m2. Donors with a pre-donation eGFR ≥90 mL/min/1.73 m2 (present in 43%) had a mean post-donation mGFR of 69 ± 10 mL/min/1.73 m2 and 5% of these donors reached an mGFR <55 mL/min/1.73 m2. A model using pre-donation serum creatinine, age and sex performed optimally, predicting mGFR with good accuracy (mean bias 2.56 mL/min/1.73 m2, R2 = 0.29, root mean square error = 11.61) and precision [bias interquartile range (IQR) 14 mL/min/1.73 m2] in the external validation cohort. This model also performed well in donors with pre-donation eGFR <90 mL/min/1.73 m2 [bias 0.35 mL/min/1.73 m2 (IQR 10)], in donors with a negative post-donation mGFR slope [bias 4.75 mL/min/1.73 m2 (IQR 13)] and in donors >65 years of age [bias 0.003 mL/min/1.73 m2 (IQR 9)].
We developed a novel post-donation mGFR prediction model based on pre-donation serum creatinine, age and sex.
活体肾捐献者筛选的挑战之一是估计捐献后的剩余肾功能。在这里,我们开发了一种新的模型,用于从预捐血清肌酐、年龄和性别预测捐后测量的肾小球滤过率(mGFR)。
在前瞻性开发队列(TransplantLines,n=511)中,构建了几种预测模型,并对其准确性、精密度和短期及长期 125I-iothalamate mGFR 后预测能力进行了测试。表现最佳的模型在特定的高危亚组(预捐 eGFR<90 mL/min/1.73 m2、5 年 mGFR 斜率下降或年龄>65 岁)中进一步进行了测试,并在内部(n=509)和外部(Mayo 诊所,n=1087)队列中进行了验证。
在开发队列中,预捐 eGFR 为 86±14 mL/min/1.73 m2,捐后 mGFR 为 64±11 mL/min/1.73 m2。预捐 eGFR≥90 mL/min/1.73 m2 的供者(占 43%)的平均捐后 mGFR 为 69±10 mL/min/1.73 m2,其中 5%的供者的 mGFR<55 mL/min/1.73 m2。使用预捐血清肌酐、年龄和性别的模型表现最佳,预测 mGFR 的准确性较高(平均偏差 2.56 mL/min/1.73 m2,R2=0.29,均方根误差=11.61),内部验证队列的精密度也较好[偏差四分位距(IQR)为 14 mL/min/1.73 m2]。该模型在预捐 eGFR<90 mL/min/1.73 m2 的供者[偏差 0.35 mL/min/1.73 m2(IQR 10)]、负捐后 mGFR 斜率的供者[偏差 4.75 mL/min/1.73 m2(IQR 13)]和年龄>65 岁的供者[偏差 0.003 mL/min/1.73 m2(IQR 9)]中也表现良好。
我们基于预捐血清肌酐、年龄和性别开发了一种新的捐后 mGFR 预测模型。